361 related articles for article (PubMed ID: 24637379)
1. An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients.
Bäckman L; Persson CA
Ann Transplant; 2014 Mar; 19():138-44. PubMed ID: 24637379
[TBL] [Abstract][Full Text] [Related]
2. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
[TBL] [Abstract][Full Text] [Related]
4. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
[TBL] [Abstract][Full Text] [Related]
5. Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.
Alloway RR; Eckhoff DE; Washburn WK; Teperman LW
Liver Transpl; 2014 May; 20(5):564-75. PubMed ID: 24493215
[TBL] [Abstract][Full Text] [Related]
6. Improvement of medication adherence with simplified once-daily immunosuppressive regimen in stable kidney transplant recipients: A prospective cohort study.
Oh CK; Bang JB; Kim SJ; Huh KH; Kim SJ; Jeon JS; Han SY; Cho HR; Kwon YJ; Lee SH; Kim YS
Asian J Surg; 2020 Jun; 43(6):660-667. PubMed ID: 31353239
[TBL] [Abstract][Full Text] [Related]
7. Conversion from twice-daily to once-daily extended-release tacrolimus in renal transplant recipients: 2-year results and review of the literature.
Tran D; Vallée M; Collette S; Senécal L; Lafrance JP; Dandavino R; Boucher A
Exp Clin Transplant; 2014 Aug; 12(4):323-7. PubMed ID: 24844288
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of once-daily modified-release tacrolimus in liver transplant recipients: a multicenter postmarketing surveillance in Japan.
Uemoto S; Abe R; Horike H; So M
Transplant Proc; 2014 Apr; 46(3):749-53. PubMed ID: 24767340
[TBL] [Abstract][Full Text] [Related]
9. Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients.
Comuzzi C; Lorenzin D; Rossetto A; Faraci MG; Nicolini D; Garelli P; Bresadola V; Toniutto P; Soardo G; Baroni GS; Adani GL; Risaliti A; Baccarani U
Transplant Proc; 2010 May; 42(4):1320-1. PubMed ID: 20534291
[TBL] [Abstract][Full Text] [Related]
10. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring.
Kuypers DR; Peeters PC; Sennesael JJ; Kianda MN; Vrijens B; Kristanto P; Dobbels F; Vanrenterghem Y; Kanaan N;
Transplantation; 2013 Jan; 95(2):333-40. PubMed ID: 23263559
[TBL] [Abstract][Full Text] [Related]
11. A Multicenter, Prospective, Observational Study of Conversion from Twice-Daily Immediate-Release to Once-Daily Prolonged-Release Tacrolimus in Liver Transplant Recipients in France: The COBALT Study.
Dumortier J; Duvoux C; Dubel L; Bazin F; Houssel-Debry P
Ann Transplant; 2019 Aug; 24():506-516. PubMed ID: 31451681
[TBL] [Abstract][Full Text] [Related]
12. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
Kim SH; Lee SD; Kim YK; Park SJ
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
[TBL] [Abstract][Full Text] [Related]
13. Adherence to, and patient convenience of, prolonged-release tacrolimus in stable kidney and liver transplant recipients after conversion from immediate-release tacrolimus in routine clinical practice in Switzerland.
Bonani M; Balaphas A; Bedino G; Bühler L; Dutkowski P; Fausch K; Gluderer S; Graf N; Hirt-Minkowski P; Müllhaupt B; Schönholzer C; Schulz MM; Venzin R; Wüthrich RP
Swiss Med Wkly; 2021 Feb; 151():w20453. PubMed ID: 33638353
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.
Meçule A; Tinti F; Poli L; Bachetoni A; Umbro I; Nofroni I; Lai Q; Pretagostini R; Berloco PB; Mitterhofer AP
Transplant Proc; 2011 May; 43(4):1024-7. PubMed ID: 21620042
[TBL] [Abstract][Full Text] [Related]
15. First clinical experience with the new once-daily formulation of tacrolimus.
First MR
Ther Drug Monit; 2008 Apr; 30(2):159-66. PubMed ID: 18367975
[TBL] [Abstract][Full Text] [Related]
16. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
Rostaing L; Bunnapradist S; Grinyó JM; Ciechanowski K; Denny JE; Silva HT; Budde K;
Am J Kidney Dis; 2016 Apr; 67(4):648-59. PubMed ID: 26717860
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of once-daily modified-release tacrolimus in kidney transplant recipients: interim analysis of multicenter postmarketing surveillance in Japan.
Takahashi K; Abe R; Usuki S; So M
Transplant Proc; 2014; 46(2):406-10. PubMed ID: 24655975
[TBL] [Abstract][Full Text] [Related]
18. Conversion to prolonged release tacrolimus formulation in stable kidney transplant recipients.
Wu SW; Tsai HC; Tsai PY; Hung TW; Chang HR; Lian JD
Swiss Med Wkly; 2013; 143():w13850. PubMed ID: 23986367
[TBL] [Abstract][Full Text] [Related]
19. Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment.
Ma MK; Kwan LP; Mok MM; Yap DY; Tang CS; Chan TM
Ren Fail; 2013 Aug; 35(7):942-5. PubMed ID: 23815459
[TBL] [Abstract][Full Text] [Related]
20. Successful conversion from twice-daily to once-daily tacrolimus in liver transplantation: observational multicenter study.
Dopazo C; Rodriguez R; Llado L; Calatayud D; Castells L; Ramos E; Molina V; García R; Fabregat J; Charco R
Clin Transplant; 2012; 26(1):E32-7. PubMed ID: 21958123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]